Nu Med Plus Stock Cash Per Share
| NUMD Stock | USD 0.01 0 10.00% |
Nu Med Plus fundamentals help investors to digest information that contributes to Nu Med's financial success or failures. It also enables traders to predict the movement of NUMD OTC Stock. The fundamental analysis module provides a way to measure Nu Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nu Med otc stock.
NUMD |
Nu Med Plus OTC Stock Cash Per Share Analysis
Nu Med's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Nu Med Plus has a Cash Per Share of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The cash per share for all United States stocks is 100.0% higher than that of the company.
NUMD Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nu Med's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nu Med could also be used in its relative valuation, which is a method of valuing Nu Med by comparing valuation metrics of similar companies.Nu Med is currently under evaluation in cash per share category among its peers.
NUMD Fundamentals
| Return On Equity | -545.23 | |||
| Return On Asset | -6.62 | |||
| Current Valuation | 1.63 M | |||
| Shares Outstanding | 81.35 M | |||
| Shares Owned By Insiders | 61.99 % | |||
| Price To Earning | 19.00 X | |||
| Price To Book | 49.86 X | |||
| EBITDA | (808.68 K) | |||
| Net Income | (830.06 K) | |||
| Cash And Equivalents | 2.54 K | |||
| Total Debt | 2.06 K | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (206.83 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 0.52 | |||
| Market Capitalization | 1.14 M | |||
| Total Asset | 22.16 K | |||
| Retained Earnings | (2.41 M) | |||
| Working Capital | (433.44 K) | |||
| Current Asset | 57.17 K | |||
| Current Liabilities | 490.62 K | |||
| Z Score | 38.4 | |||
| Net Asset | 22.16 K |
About Nu Med Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nu Med Plus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nu Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nu Med Plus based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in NUMD OTC Stock
Nu Med financial ratios help investors to determine whether NUMD OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NUMD with respect to the benefits of owning Nu Med security.